Vertex Pharmaceuticals Inc. buy Bank of America Co.
Start price
10.03.26
/
50%
€432.95
Target price
10.03.27
€514.40
Performance (%)
-13.00%
Price
14.04.26
€376.65
Summary
This prediction is currently active. The price of Vertex Pharmaceuticals Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -13.00%. This prediction currently runs until 10.03.27. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | 1.141% | 1.141% |
| iShares Core DAX® | 3.023% | 2.202% |
| iShares Nasdaq 100 | 3.561% | 1.325% |
| iShares Nikkei 225® | 6.618% | 5.707% |
| iShares S&P 500 | 2.635% | 1.008% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals (VRTX) had its price target raised by Bank of America Corporation from $571.00 to $598.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€456.50
31.03.25
31.03.25
€523.00
31.03.26
31.03.26
-15.75%
01.04.26
01.04.26
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€377.00
19.12.24
19.12.24
€503.63
19.12.25
19.12.25
3.34%
20.12.25
20.12.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€444.75
14.10.24
14.10.24
€496.10
14.10.25
14.10.25
-20.33%
15.10.25
15.10.25